Determining hepatic triglyceride production in mice: Comparison of poloxamer 407 with Triton WR-1339

Journal of Lipid Research

Volumn 46, Issue 9, 2005, Pages 2023-2028

  Millar, John S ^a   Cromley, Debra A ^a   McCoy, Mary G ^a   Rader, Daniel J ^a   Billheimer, Jeffrey T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hepatic lipids; Lipoproteins; Non ionic detergents

Indexed keywords

DETERGENT; LIPOPROTEIN LIPASE; POLOXAMER; TRIACYLGLYCEROL; TYLOXAPOL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HYDROLYSIS; LIPID ANALYSIS; LIPID LIVER LEVEL; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEINS E; CHEMISTRY, PHYSICAL; ENZYME INHIBITORS; HYDROLYSIS; KINETICS; LIPOPROTEIN LIPASE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLOXAMER; POLYETHYLENE GLYCOLS; RECEPTORS, LDL; SURFACE-ACTIVE AGENTS; TRIGLYCERIDES;

EID: 24344490760     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.D500019-JLR200     Document Type: Article

References (29)

1. Ginsberg, H. N. (2001). Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy. Am. J. Cardiol. 87: 1174-1180.
2. Kellner, A., J. W. Correll, and A. T. Ladd. 1951. Sustained hyperlipemia induced in rabbits by means of intravenously injected surface-active agents. J. Exp. Med. 93: 373-384.
3. Schotz, M. C., A. Scanu, and I. H. Page. 1957. Effect of Triton on lipoprotein lipase of rat plasma. Am. J. Physiol. 188: 399-402.
4. van Vlijmen, B. J., A. Rohlmann, S. T. Page, A. Bensadoun, I. S. Bos, T. J. van Berkel, L. M. Havekes, and J. Herz. 1999. An extrahepatic receptor-associated protein-sensitive mechanism is involved in the metabolism of triglyceride-rich lipoproteins. J. Biol. Chem. 274: 35219-35226.
5. Chen, Z., R. L. Fitzgerald, M. R. Averna, and G. Schonfeld. 2000. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides. J. Biol. Chem. 275: 32807-32815.
6. Li, X., F. Catalina, S. M. Grundy, and S. Patel. 1996. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48- relative to B-100-containing lipoproteins. J. Lipid Res. 37: 210-220.
7. Hirano, T., T. Takahashi, S. Saito, H. Tajima, T. Ebara, and M. Adachi. 2001. Apoprotein C-III deficiency markedly stimulates triglyceride secretion in vivo: comparison with apoprotein E. Am. J. Physiol. Endocrinol. Metab. 281: E665-E669.
8. Millar, J. S., C. Maugeais, I. V. Fuki, and D. J. Rader. 2002. Normal production rate of apolipoprotein B in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 22: 989-994.
9. Shimizugawa, T., M. Ono, M. Shimamura, K. Yoshida, Y. Ando, R. Koishi, K. Ueda, T. Inaba, H. Minekura, T. Kohama, et al. 2002. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J. Biol. Chem. 277: 33742-33748.
10. Riddle, T. M., N. M. Schildmeyer, C. Phan, C. J. Fichtenbaum, and D. Y. Hui. 2002. The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice. J. Lipid Res. 43: 1458-1463.
11. Kuipers, F., M. C. Jong, Y. Lin, M. Eck, R. Havinga, V. Bloks, H. J. Verkade, M. H. Hofker, H. Moshage, T. J. Berkel et al. 1997. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes. J. Clin. Invest. 100: 2915-2922.
12. Linden, D., M. Alsterholm, H. Wennbo, and J. Oscarsson. 2001. PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins. J. Lipid Res. 42: 1831-1840.
13. Ishikawa, T., and N. Fidge. 1979. Changes in the concentration of plasma lipoproteins and apoproteins following the administration of Triton WR 1339 to rats. J. Lipid Res. 20: 254-264.
14. Trout, J. J., and J. M. Viles. 1979. Cellular changes associated with Triton WR-1339 accumulation in rat hepatocytes. I. Autophagy. Exp. Mol. Pathol. 30: 230-241.
15. Trout, J. J., and J. M. Viles. 1979. Cellular changes associated with Triton WR-1339 accumulation in rat hepatocytes. II. Lysosomal Triton WR-1339 accumulation. Exp. Mol. Pathol. 31: 81-90.
16. Zeniya, M., and A. Reuben. 1988. Triton WR-1339-induced changes in serum lipids and biliary lipid secretion. Am. J. Physiol. 254: G346-G354.
17. Kabanov, A. V., E. V. Batrakova, and V. Y. Alakhov. 2002. P-407 block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release. 82: 189-212.
18. Johnston, T. P. 2004. The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: a review of findings to date. J. Cardiovasc. Pharmacol. 43: 595-606.
19. Palmer, W. K., E. E. Emeson, and T. P. Johnston. 1998. Poloxamer 407-induced atherogenesis in the C57BL/6 mouse. Atherosclerosis. 136: 115-123.
20. Miao, B., S. Zondlo, S. Gibbs, D. Cromley, V. Hosagrahara, T. Kirchgessner, J. Billheimer, and R. Mukherjee. 2004. Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J. Lipid Res. 45: 1410-1417.
21. Schurr, P. E., J. R. Schnitz, and T. M. Parkinson. 1972. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs. Lipids. 7: 68-74.
22. Otvos, J. D. 2002. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin. Lab. 48: 171-180.
23. McCoy, M. G., G. S. Sun, D. Marchadier, C. Maugeais, J. M. Click, and D. J. Rader. 2002. Characterization of the lipolytic activity of endothelial lipase. J. Lipid Res. 43: 921-929.
24. Matthews, C. M. 1957. The theory of tracer experiments with iodine-131-labelled plasma proteins. Phys. Med. Biol. 2: 36-53.
25. Boonchan, S., M. L. Britz, and G. A. Stanley. 1998. Surfactant-enhanced biodegradation of high molecular weight polycyclic aromatic hydrocarbons by Stenotrophomonas maltophilia. Biotechnol. Bioeng. 59: 482-494.
26. Henning, R., and H. Plattner. 1975. Formation of Triton WR 1339-filled rat liver lysosomes. I. Properties and intracellular distribution of [3H] triton WR 1339. Exp. Cell Res. 94: 363-376.
27. Mensenkamp, A. R., L. M. Havekes, J. A. Romijn, and F. Kuipers. 2001. Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E. J. Hepatol. 35: 816-822.
28. Twisk, J., D. L. Gillian-Daniel, A. Tebon, L. Wang, P. H. Barrett, and A. D. Attie. 2000. The role of the LDL receptor in apolipoprotein B secretion. J. Clin. Invest. 105: 521-532.
29. Li, C., W. K. Palmer, and T. P. Johnston. 1996. Disposition of poloxamer 407 in rats following a single intraperitoneal injection assessed using a simplified colorimetric assay. J. Pharm. Biomed. Anal. 14: 659-665.